The FDA met Thursday December 8, 2011 to speak with a panel of experts regarding growing concern that Yaz and other drospirenone-containing drugs increase a patient’s risk of developing blood clots in the lungs and legs. Experts weighed in on this issue and cited 5 large studies that supported the argument that drugs such as Yaz and Yasmin, which contain the manmade hormone drospirenone, do increase the chance of developing dangerous blood clots that could trigger heart attacks, strokes, and blockages in the lungs. In fact, one study by the FDA found that women taking Yasmin had a 75% higher chance of suffering a blood clot when compared to patients taking other older formulations of birth control drugs.
The FDA has not set a deadline for the change in labeling that will advise Yaz patients of the increased risk for blood clots. If you or a loved one has taken Yaz, Yasmin, or another drospirenone-containing birth control pill and has suffered an injury please contact our office today to speak with one of our product liability/personal injury attorneys to discuss your legal options.